Head-to-Head

Bristol-Myers Squibb Co. vs. Johnson & Johnson

BMY

Bristol-Myers Squibb Co.

$62.84 -1.19%

VS JNJ

Johnson & Johnson

$271.63 +0.52%

Bristol-Myers Squibb Co. (BMY) comes out ahead, leading on 7 of 11 compared factors.

Size & Scale

BMYJNJ
Market Cap $129.92 billion $651.20 billion
Revenue (TTM) $49.19 billion $97.93 billion
Net Income (TTM) $9.27 billion $21.04 billion

JNJ leads on 3 of 3 size & scale factors.

Valuation

BMYJNJ
P/E Ratio 13.84 31.51
Price / Book 5.82 7.66
Price / Sales 2.64 6.65

BMY leads on 3 of 3 valuation factors.

Profitability

BMYJNJ
Net Margin 18.85% 21.48%
Return on Equity 41.55% 24.76%

BMY and JNJ split the profitability factors evenly.

Dividend

BMYJNJ
Dividend Yield 4.01% 1.97%
Payout Ratio 55.51 62.18

BMY leads on 2 of 2 dividend factors.

Risk & Sentiment

BMYJNJ
Short Interest 0.39% 0.67%

BMY leads on 1 of 1 risk & sentiment factors.

Dig deeper: BMY overview, BMY financials, JNJ overview, JNJ financials.

Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.